Introduction
Coronavirus-induced respiratory diseases in human first reported in Wuhan, China on December 31, 2019 quickly broke out in other parts of China and other countries (1, 2). The entire human population is at risk for contracting coronavirus disease (COVID-19)(3). Given the immune and anatomical changes during pregnancy, pregnant women are more vulnerable to the virus. The COVID-19 pandemic can therefore cause serious consequences for pregnant women (4-7). The clinical features and effects of COVID-19 during pregnancy and the prenatal outcomes of COVID-19 patients have rarely been addressed in literature (8). Moreover, COVID-19 associated infections have never been reported in molar pregnancy (9). Clinical experience with managing pregnant women and newborns with COVID-19 is also limited in China(10).